Streetwise Live! Presents Algernon Pharmaceuticals on 01/27/2022. Learn More

Sector Expert: Rick Wise

Leerink Partners LLC

Image: Rick Wise

Prior to joining Leerink Swann in 2008, Frederick "Rick" Wise was a senior managing director and medical supplies and devices analyst with Bear Stearns for 22 years. For the past 13 years, he has been a member of the Institutional Investor All-America Research Team, most recently with a runner-up ranking in the 2009 poll. He was also ranked #4 in the 2006, 2007, and 2008 Greenwich Associates U.S. Equity Analysts poll. Prior to joining Bear Stearns, Wise served as an analyst at Kidder, Peabody & Co. and at Forbes, Inc. Wise received a master's degree.and a bachelor's degree from the Manhattan School of Music. He is also a Chartered Financial Analyst.

Recent Interviews

Small-Cap Ideas with Double-Digit Growth Potential: Frederick "Rick" Wise (4/5/12)

You can own large medtech and diversified medical supply companies for low volatility and incremental upside in a trending economy (yawn. . .), but small- and mid-cap companies offer the real double-digit growth possibilities. In this exclusive interview with The Life Sciences Report, Analyst and Managing Director Frederick "Rick" Wise of Leerink Swann shares small-cap ideas that could wake up investors' portfolios.

Due to permission requirements, not all quotes are shown.